Day: April 14, 2022

AS Inbank announces its decision to redeem, pre-term, the subordinated bonds issued on 28 September 2016, registered under ISIN code EE3300110964 (hereinafter Inbank 2026 subordinated bonds). Early redemption is carried out in accordance with the Listing and Admission to Trading Prospectus of the Inbank 2026 Subordinated Bonds and the Terms of the Bonds, according to which the Bonds may be redeemed prematurely wholly or partly after 28 September 2021 by notifying the investors thereof at least 30 days in advance and upon the prior consent of the Financial Supervision Authority. With its Management Board resolution from 4 April 2022, the Financial Supervision Authority has given its consent to early redemption. All 6,503 AS Inbank 2026 subordinated bonds with a nominal value of EUR 1,000 and total value of EUR 6,503,000 will be subject...

 Brimonidine tartrate/timolol maleate combination eyedrop is used to treat elevated eye pressure in patients with ocular hypertension1Ocular hypertension affects over 5% of all adults2; the eye does not properly drain fluid, causing eye pressure to build up3Sandoz manufactures high-impact medicines that bring savings to US patients and support the sustainability of the overall US healthcare systemBasel, April 14, 2022 — Sandoz, a global leader in generic and biosimilar medicines, today announced the US launch of its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, an AB-rated generic equivalent to AbbVie’s COMBIGAN®*, to lower eye pressure in patients with ocular hypertension (high eye pressure).1 This prescription eyedrop is immediately available to patients via retail pharmacies....

Fairport, NY., April 14, 2022 (GLOBE NEWSWIRE) — Vinco Ventures, Inc. (NASDAQ:BBIG), a digital media and content technologies holding company, will release its financial results for the fourth quarter and full year ended December 31, 2021, on Friday, April 15, 2022. Management will hold a conference call and webcast on Monday, April 18, 2022 at 8:30 a.m. ET to review and discuss the results. An audio archive of the conference call will be available until April 25, 2022 at 11:59 p.m. ET, while a recorded version of the webcast will be available after the call and accessible at https://investors.vincoventures.com/.What:  Vinco Ventures’ Fourth Quarter and Full Year 2021 Financial Results Conference CallWhen: Monday, April 18, 2022Time: 8:30 a.m. ETLive Call: (877) 407-2991, (U.S.)  (201) 389-0925, (International)Replay: (877)...

VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) — Patriot Battery Metals Inc. (the “Company” or “Patriot”) (CSE: PMET) (OTCQB: PMETF) (FSE: R9GA) is pleased to announce the appointment of Mr. Jon Christian Evensen as a Director of the Company effective immediately. Mr. Evensen is a private investor with 10 years’ experience in investment banking and investment management focused on natural resources. While at Luminus Management, he built the global metals & mining sector vertical to deploy over $1 billion gross capital in a cross asset strategy including public equities, opportunistic credit, commodity futures, private investments, and opportunistic physical commodities. In addition to his time at Luminus, he covered the metals & mining industry while at Millennium and a number of start-up hedge funds. Before...

VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) today announced that its April 2022 distribution of $0.0946 per unit has been declared and is payable to unitholders of record as of April 21, 2022. The April 2022 distribution will be paid on April 29, 2022. The Fund is a limited purpose, open-ended trust established under the laws of the Province of Ontario that, through The Keg Rights Limited Partnership, a subsidiary of the Fund, owns certain trademarks and other related intellectual property used by Keg Restaurants Ltd. (“KRL”). In exchange for use of those trademarks, KRL pays the Fund a royalty of 4% of gross sales of Keg restaurants included in the royalty pool. Vancouver-based KRL is the leading operator and franchisor of steakhouse restaurants in Canada...

PERTH, Western Australia, April 13, 2022 (GLOBE NEWSWIRE) — Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss the March 2022 Quarterly Report, which is anticipated for release around 8:30am AEDT on Tuesday April 26, 2022. CALL DETAILSAustralia: Tuesday April 26, 2022 Perth – 7:00am Sydney/Melbourne – 9:00am Canada: Monday April 25, 2022 Toronto – 7:00pm Vancouver – 4:00pm UK: Tuesday April 26, 2022 London – 12:00amRegister for the investor webinar at the link below: https://us02web.zoom.us/webinar/register/WN_BlNlcn9gTjmVUsR1WWri8A After registering, you will receive a confirmation email containing information about joining the webinar. To join the webinar via telephone, please use one of the following numbers and enter the Webinar ID: 814 9279 7984 For higher quality, dial...

Figure 3 Inflation versus devaluation from April 2011- March 2022BRISBANE, Australia, April 14, 2022 (GLOBE NEWSWIRE) — Allkem Limited (ASX|TSX: “AKE”, the “Company”) provides an update on its global lithium portfolio, business activities and financial position1 at 31 March 2022. HIGHLIGHTS ALLKEM STRATEGYPlans to increase lithium production 3-fold by 2026 and maintain a 10% share of the global lithium market over the next decade were outlined at an investor briefing in early April 2.5x increase in the resource at Olaroz from 6.4 million tonnes (“Mt”) lithium carbonate equivalent (“LCE”) to 16.2 Mt LCE Total Allkem resources at the Olaroz and immediately adjacent Cauchari basins are now 22.5 Mt LCE in all resource categories, making it one of the largest lithium resources in the world 40% increase in lithium carbonate production...

IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), announced today the pricing of an underwritten public offering of 26,266,417 shares of its common stock, together with warrants to purchase up to an aggregate of 13,133,208.5 shares of its common stock. Each share of common stock is being sold together with one warrant to purchase 0.5 shares of common stock at a combined offering price of $1.3325 for total gross proceeds of approximately $35 million, before underwriting discounts and commissions and offering expenses payable by Oncocyte. The warrants have an exercise price of $1.53 per share, are exercisable immediately, and will expire five years following the date of issuance. The offering is expected to close on or about April 19, 2022, subject to the satisfaction...